Virtual Patent Marking

The following RxAnte® products, technology or portions thereof (“RxAnte Technology”) are protected in the United States by the US patents specified below.   Additional patent applications may be pending.

RxAnte Technology US Patent Number
RxEffect U.S. Patent 10,108,975
Value of Future Adherence (VFA) U.S. Patent 10,318,897; andUS Patent 10,707,372


This page is intended to satisfy virtual patent marking provisions of various jurisdictions, and is intended to serve as notice under 35 U.S.C § 287(a) of the Leahy-Smith America Invents Act, also known as the Patent Reform Act of 2011.


Last Updated:  1/5/2021